|
Name |
13-Methyltetradecanoic acid
|
Molecular Formula | C15H30O2 | |
IUPAC Name* |
13-methyltetradecanoic acid
|
|
SMILES |
CC(C)CCCCCCCCCCCC(=O)O
|
|
InChI |
InChI=1S/C15H30O2/c1-14(2)12-10-8-6-4-3-5-7-9-11-13-15(16)17/h14H,3-13H2,1-2H3,(H,16,17)
|
|
InChIKey |
ZOCYQVNGROEVLU-UHFFFAOYSA-N
|
|
Synonyms |
13-Methyltetradecanoic acid; 13-methylmyristic acid; 2485-71-4; Isopentadecanoic acid; Isopentadecylic acid; Subtilopentadecanoic acid; 13-METHYLTETRADECANOICACID; 13-Mtd; LeDSF3; M09T9M1LTY; 13-methyl-tetradecanoic acid; 13-Methyl tetradecanoic acid; Tetradecanoic acid, 13-methyl-; CHEBI:39250; 13-Methylmyristate; UNII-M09T9M1LTY; iso-pentadecanoic acid; iso-C15; 13-Methyl-tetradecansaeure; iso-C15:0; 15:0 iso; SCHEMBL366393; CHEMBL495851; DTXSID90179552; i-C15:0; ZINC1911381; LMFA01020009; i-15:0; HY-131503; CS-0136053; FT-0714166; 13-Methylmyristic acid, >=98% (capillary GC); A928069; J-015704; Q20179071
|
|
CAS | 2485-71-4 | |
PubChem CID | 151014 | |
ChEMBL ID | CHEMBL495851 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 242.4 | ALogp: | 5.5 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 12 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 37.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 17 | QED Weighted: | 0.468 |
Caco-2 Permeability: | -4.823 | MDCK Permeability: | 0.00002320 |
Pgp-inhibitor: | 0.017 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.519 |
30% Bioavailability (F30%): | 0.962 |
Blood-Brain-Barrier Penetration (BBB): | 0.164 | Plasma Protein Binding (PPB): | 98.48% |
Volume Distribution (VD): | 0.405 | Fu: | 1.23% |
CYP1A2-inhibitor: | 0.225 | CYP1A2-substrate: | 0.195 |
CYP2C19-inhibitor: | 0.086 | CYP2C19-substrate: | 0.354 |
CYP2C9-inhibitor: | 0.342 | CYP2C9-substrate: | 0.991 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.047 |
CYP3A4-inhibitor: | 0.016 | CYP3A4-substrate: | 0.03 |
Clearance (CL): | 2.458 | Half-life (T1/2): | 0.682 |
hERG Blockers: | 0.026 | Human Hepatotoxicity (H-HT): | 0.034 |
Drug-inuced Liver Injury (DILI): | 0.054 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.03 | Maximum Recommended Daily Dose: | 0.013 |
Skin Sensitization: | 0.772 | Carcinogencity: | 0.07 |
Eye Corrosion: | 0.974 | Eye Irritation: | 0.98 |
Respiratory Toxicity: | 0.821 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000551 | 0.774 | D0Z5BC | 0.509 | ||||
ENC001519 | 0.764 | D0O1PH | 0.487 | ||||
ENC002101 | 0.729 | D0P1RL | 0.475 | ||||
ENC000548 | 0.724 | D07ILQ | 0.466 | ||||
ENC003362 | 0.707 | D05ATI | 0.446 | ||||
ENC000378 | 0.704 | D0E4WR | 0.439 | ||||
ENC002465 | 0.695 | D0XN8C | 0.432 | ||||
ENC001160 | 0.689 | D0Z5SM | 0.403 | ||||
ENC000102 | 0.686 | D0I4DQ | 0.381 | ||||
ENC005537 | 0.684 | D0G2KD | 0.380 |